Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Inventory (2024 - 2025)

Historic Inventory for Zevra Therapeutics (ZVRA) over the last 2 years, with Q3 2025 value amounting to $1.4 million.

  • Zevra Therapeutics' Inventory changed N/A to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2024, which is N/A changed from last year.
  • Per Zevra Therapeutics' latest filing, its Inventory stood at $1.4 million for Q3 2025.
  • Zevra Therapeutics' Inventory's 5-year high stood at $2.6 million during Q1 2025, with a 5-year trough of $1.1 million in Q2 2025.